82 related articles for article (PubMed ID: 20524424)
1. Studies of the degradation mechanism of pyrrolo[3,4-c] pyridine-1,3(2H)-dione derivatives with analgesic activity: isolation and identification of products and summary.
Muszalska I
Acta Pol Pharm; 2010; 67(3):233-8. PubMed ID: 20524424
[TBL] [Abstract][Full Text] [Related]
2. Investigations on the synthesis and pharmacological properties of N-substituted derivatives of 4-alkoxy-6-methyl-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones.
Sladowska H; Filipek B; Szkatuła D; Sapa J; Bednarski M; Ciołkowska M
Farmaco; 2005 Jan; 60(1):53-9. PubMed ID: 15652370
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of solvolysis of N-[2-(4-o-fluorophenylpiperazin-1-yl)ethyl]-2,5-dimethyl-1-phenylpyrrole-3,4-dicarboximide (PDI).
Sobczak A; Zajac M; Malinka W; Redzicka A
Acta Pol Pharm; 2010; 67(3):225-32. PubMed ID: 20524423
[TBL] [Abstract][Full Text] [Related]
4. Stability of new analgesic active compound, pyrrolo-[3,4-c]pyridine derivative, in aqueous solutions.
Muszalska I; Wojtyniak E
Acta Pol Pharm; 2007; 64(4):319-25. PubMed ID: 18536157
[TBL] [Abstract][Full Text] [Related]
5. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.
Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J
J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475
[TBL] [Abstract][Full Text] [Related]
6. (1)H,(13)C and (19)F NMR data of N-substituted 6-(4-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amines in DMSO-d(6).
Sørum C; Simić N; Sundby E; Hoff BH
Magn Reson Chem; 2010 Mar; 48(3):244-8. PubMed ID: 20041453
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and properties of 2-(4-substituted)butyl derivatives of some 2,3-dihydro-1,3-dioxo-1H-pyrrolo[3,4-c]pyridines.
Sladowska H; Szkatuła D; Filipek B; Maciag D; Sapa J; Zygmunt M
Pharmazie; 2001 Feb; 56(2):133-8. PubMed ID: 11234340
[TBL] [Abstract][Full Text] [Related]
8. Forced Degradation and Photodegradation Studies of Pyrrolo[3,4-c]pyridine-1,3-dione Derivatives as Analgesic Active Compounds Using HPLC, UV and IR Spectrometry, and HPLC/MS Methods.
Muszalska I; Ciemniejewski MP; Lesniewska MA; Szkatuła D; Malinka W
J AOAC Int; 2015; 98(5):1248-59. PubMed ID: 26525243
[TBL] [Abstract][Full Text] [Related]
9. Isolation and structure determination of oxidative degradation products of atorvastatin.
Kracun M; Kocijan A; Bastarda A; Grahek R; Plavec J; Kocjan D
J Pharm Biomed Anal; 2009 Dec; 50(5):729-36. PubMed ID: 19615842
[TBL] [Abstract][Full Text] [Related]
10. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and properties of 4-alkoxy-2-[2-hydroxy-3-(4-o,m,p-halogenoaryl-1 -piperazinyl)propyl]-6-methyl-1H-pyrrolo-[3,4-c]pyridine-1,3(2H)-diones with analgesic and sedative activities.
Sladowska H; Sabiniarz A; Szkatuła D; Filipek B; Sapa J
Acta Pol Pharm; 2006; 63(4):245-54. PubMed ID: 17203859
[TBL] [Abstract][Full Text] [Related]
12. Exploring the "forgotten"-OH NMR spectral region in natural products.
Charisiadis P; Exarchou V; Troganis AN; Gerothanassis IP
Chem Commun (Camb); 2010 May; 46(20):3589-91. PubMed ID: 20376399
[TBL] [Abstract][Full Text] [Related]
13. Hydrolytic degradation of azimsulfuron, a sulfonylurea herbicide.
Boschin G; D'Agostina A; Antonioni C; Locati D; Arnoldi A
Chemosphere; 2007 Jul; 68(7):1312-7. PubMed ID: 17328940
[TBL] [Abstract][Full Text] [Related]
14. Identification of imatinib mesylate degradation products obtained under stress conditions.
Szczepek WJ; Kosmacińska B; Bielejewska A; Łuniewski W; Skarzyński M; Rozmarynowska D
J Pharm Biomed Anal; 2007 Apr; 43(5):1682-91. PubMed ID: 17307328
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological properties of new derivatives of 4-alkoxy-6-methyl-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones.
Sladowska H; Sabiniarz A; Sapa J; Filipek B
Acta Pol Pharm; 2009; 66(1):57-63. PubMed ID: 19226970
[TBL] [Abstract][Full Text] [Related]
16. Chemical investigation of decomposition processes of pyrazolidine-3,5-dione derivatives. Part 3. Kinetics and mechanism of degradation of ketazone in aqueous solutions and solid phase.
Wachowiak R
Pol J Pharmacol Pharm; 1978; 30(6):833-43. PubMed ID: 39293
[TBL] [Abstract][Full Text] [Related]
17. 1H and 13C NMR spectra of C-6 and C-9 substituted 3-azabicyclco[3.3.1]nonanes.
Goodall K; Brimble M; Barker D
Magn Reson Chem; 2008 Jan; 46(1):75-9. PubMed ID: 18041010
[TBL] [Abstract][Full Text] [Related]
18. Investigation of N-hydroxythalidomide in vitro stability and comparison to other N-substituted derivatives.
Estour F; Ferranti V; Chabenat C; Toussaint E; Galons H; Lafont O
J Pharm Biomed Anal; 2007 Oct; 45(2):237-42. PubMed ID: 17656059
[TBL] [Abstract][Full Text] [Related]
19. Major degradation product identified in several pharmaceutical formulations against the common cold.
Marín A; Espada A; Vidal P; Barbas C
Anal Chem; 2005 Jan; 77(2):471-7. PubMed ID: 15649042
[TBL] [Abstract][Full Text] [Related]
20. Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy.
Walker GS; Atherton J; Bauman J; Kohl C; Lam W; Reily M; Lou Z; Mutlib A
Chem Res Toxicol; 2007 Jun; 20(6):876-86. PubMed ID: 17536843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
